The Food and Drug Administration (FDA) has approved Imuldosa â„¢ (ustekinumab-srlf), a biosimilar to Stelara ® (ustekinumab), for the treatment of various chronic inflammatory diseases. Imuldosa, ...
Some results have been hidden because they may be inaccessible to you